Edward R. Conner Net Worth

The estimated Net Worth of Edward R. Conner is at least $108 Thousand dollars as of 7 January 2019. Edward Conner owns over 5,000 units of Imara Inc stock worth over $108,230 and over the last 8 years Edward sold IMRA stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Edward Conner IMRA stock SEC Form 4 insiders trading

Edward has made over 14 trades of the Imara Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently Edward exercised 5,000 units of IMRA stock worth $16,000 on 7 January 2019.

The largest trade Edward's ever made was exercising 5,000 units of Imara Inc stock on 7 January 2019 worth over $16,000. On average, Edward trades about 3,043 units every 17 days since 2016. As of 7 January 2019 Edward still owns at least 17,125 units of Imara Inc stock.

You can see the complete history of Edward Conner stock trades at the bottom of the page.

What's Edward Conner's mailing address?

Edward's mailing address filed with the SEC is 501 Canal Blvd, Richmond, CA 94804, USA.

Insiders trading at Imara Inc

Over the last 5 years, insiders at Imara Inc have traded over $7,889,059 worth of Imara Inc stock and bought 11,496,717 units worth $107,874,489 . The most active insiders traders include David M Mott, Lundbeck A S H, and Capital Management, L.P.Ra .... On average, Imara Inc executives and independent directors trade stock every 23 days with the average trade being worth of $1,965,179. The most recent stock trade was executed by Michael Gray on 22 February 2023, trading 9,856 units of IMRA stock currently worth $46,028.

What does Imara Inc do?

Imara Inc. is a clinical-stage biotechnology company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin. Imara is currently advancing IMR-687, a highly selective, potent small molecule inhibitor of PDE9 that is an oral, once-a-day, potentially disease-modifying treatment for sickle cell disease and beta-thalassemia.

Complete history of Edward Conner stock trades at Sangamo Therapeutics Inc and Imara Inc

Imara Inc executives and stock owners

Imara Inc executives and other stock owners filed with the SEC include:

• Rahul D. Ballal,
  Chief Executive Officer
• Edward R. Conner,
  Director
• Enterprise Associates 14, L...,
  
• Springs Capital Management ...,
  
• Lundbeck A S H,
  10% owner
• City Capital Llc Bay City C...,
  
• Venture Investments, Llc Al...,
  10% owner
• Invest A/S Lundbeckfond,
  10% owner
• Bioscience Plc Arix Bioscie...,
  
• Capital Management, L.P.Ra ...,
  
• Advisors Llc Orbi Med Capit...,
  
• James G Mc Arthur,
  Director
• Carlbay City Capital Llc Ba...,
  
• Mette Kirstine Agger,
  Director
• David P Bonita,
  Director
• Barbara Dalton,
  Director
• Sara M. Nayeem,
  Director
• David M Mott,
  Director
• Inc Pfizer Ventures (Us) Ll...,
  
• Enterprise Associates 14, L...,
  
• Michael Gray,
  CFO & COO
• Kenneth Attie,
  SVP, CMO
• Laura A Williams,
  Director
• Carl Goldfischer,
  Director
• Mark Chin,
  Director
• Advisors Llc Orbi Med Capit...,
  
• Braden Michael Leonard,
  10% owner
• Enterprise Associates 14, L...,
  
• Enterprise Associates 14, L...,
  
• Enterprise Associates 14, L...,
  
• Capital Lp Commodore,
  10% owner